Echo Therapeutics (ECTE) Prices 3.2M Offering at 95c/Share

Echo Therapeutics, Inc. (Nasdaq: ECTE) today announced the pricing of a previously announced underwritten public offering of 3,200,000 shares of its common stock, offered at a price to the public of $0.95 per share. The gross proceeds to Echo from this offering are expected to be approximately $3.0 million, before deducting the underwriting discount and other estimated offering expenses payable by Echo. Echo Therapeutics has granted the underwriters a 45-day option to purchase up to an aggregate of 480,000 additional shares of its common stock to cover over-allotments, if any. The offering is expected to close on or about December 27, 2012, subject to customary closing conditions.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Full Circle Lithium closes $5.14M private placement
• Yxt.com Group prices $1.5M registered direct offering at $3 per ADS
• MicroVision prices $17 million public offering at $2.50 per unit